THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.

Search
Close this search box.
Abbreviations

Abbreviations

GMB

Adult glioblastoma

pHGG

Paediatric high-grade glioma

UNCAN

EU initiative for understanding cancer

MRI

Magnetic resonance imaging 

SOC

Standard of care

I/O

Immuno-oncology

TTF

Tumour treating fields

The GLIOMATCH project has officially started in January 2024

Under the coordination of KU Leuven, the consortium of partners from diverse disciplines, including clinical experts, medical practitioners, data scientists, and health economists, will be working on pioneering personalised therapies for brain cancer patients.

More Posts

European Cancer Summit 2024

GLIOMATCH was featured at the European Cancer Summit 2024, held on 20–21 November in Brussels and online. We’re proud to support Europe’s fight against cancer.

Belgian Science Day 2024

GLIOMATCH project coordinator, Prof Frederik de Smet, held a lecture about how immunotherapy can be harnessed for brain cancer research.

July 2024 is Glioblastoma Awareness Month

Glioblastoma Awareness Day (GBM Day) on 17 July 2024 aimed to raise awareness and support for those affected by glioblastoma, an aggressive brain tumour. GLIOMATCH’s month-long campaign is summarised in this article, highlighting the critical need for further research.